Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Raven Biotechnologies begins phase I/IIa trial of RAV-12 in GI cancers

Jan. 13, 2005

Treatment begins in phase I study of IMC-1121B in patients with solid tumors

Jan. 11, 2005

Phase III protocol submitted for Multikine

Jan. 11, 2005

Nippon Kayaku to develop IL13-PE38QQR in Japan

Jan. 11, 2005

Preclinical evidence for the antitumor efficacy of panitumumab in breast cancer

Jan. 3, 2005

APC-8024 shows antitumor activity in patients with advanced breast cancer

Jan. 3, 2005

IgG1 monoclonal antibodies for cancer therapy prepared and tested at Crucell

Dec. 30, 2004

IND approved for phase II trial of AVR-118 in advanced malignancies

Dec. 29, 2004

Lumiliximab shows antitumor activity in patients with relapsed/refractory CLL

Dec. 27, 2004

Phase II study of p53 vaccine shows stabilization in patients with advanced breast cancer

Dec. 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026